Printer Friendly

CONCEPTUS INC. NAMES KATHRYN TUNSTALL ZOBEL PRESIDENT AND CHIEF EXECUTIVE OFFICER

 FREMONT, Calif., Aug. 17 /PRNewswire/ -- Conceptus Inc. today announced that Kathryn Tunstall Zobel, 43, has been appointed president and chief executive officer, effective immediately. Tunstall Zobel, previously president of the Edwards LIS Division of Baxter Healthcare Corp., succeeds Chairman and acting Chief Executive Officer Richard Randall, who remains chairman of the board. Randall is also chairman of Target Therapeutics Inc., an initial principal stockholder of Conceptus.
 "Kathryn brings to Conceptus a superior knowledge of medical device technology and a proven ability to identify and develop promising R&D projects through to commercialization," said Randall, who has served as chairman and acting president of Conceptus since its formation in January 1993. "The board and I are very pleased to have her leading Target Therapeutics technology into the field of reproductive disorders."
 Tunstall Zobel has spent nearly 20 years in the healthcare products field, holding a variety of positions at American Hospital Supply Corp., at McGaw Laboratories and, most recently, at the Edwards LIS Division of Baxter Healthcare Corporation.
 "Infertility is a problem that affects millions of people worldwide," said Randall. "With Kathryn on board, Conceptus can move full speed ahead with products already developed by Target to address this significant medical need."
 Conceptus Inc. was founded in January 1993 by Target Therapeutics Inc. (NASDAQ: TGET) and venture capital funds associated with new Enterprise Associates to use Target Therapeutics catheter, guidewire and micro-coil technologies in providing less invasive and less costly medical approaches than are currently available in the diagnosis and treatment of male and female reproductive disorders, such as infertility and impotence.
 -0- 8/16/93
 /CONTACT: Kathryn Tunstall Zobel of Conceptus, 510-440-7881; or Bruce Voss of Edelman Public Relations, 415-433-5381, for Conceptus/
 (TGET)


CO: Conceptus Inc.; Target Therapeutics Inc. ST: California IN: HEA SU: PER

CB-LH -- SF002 -- 3592 08/17/93 13:30 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 17, 1993
Words:304
Previous Article:MARTECH USA CLEANS UP TAMPA BAY OIL SPILL
Next Article:AIR RESOURCES BOARD OKS OIL COMPANY VARIANCES; INSURES STEADY SUPPLY OF DIESEL FUEL
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters